Ventricular Assistance Devices Global Market - Forecast to 2023

  • ID: 4308267
  • Report
  • Region: Global
  • 275 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 6
The Ventricular Assist Devices Global Market is Expected to Grow at Double Digit CAGR to Reach $2,850.1 Million by 2023

FEATURED COMPANIES

  • Abbott Laboratories
  • Berlin Heart Gmbh
  • Corwave
  • Fineheart Sarl
  • Leviticus-Cardio Ltd.
  • Mitiheart Corporation
  • MORE

The heart conditions are considered advanced or end stage heart failure, when conventional heart therapies and management strategies no longer work. The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for end-stage heart failure. The availability of donor hearts is insufficient to meet the required demand and many patients are not eligible for transplantation due to age and other health conditions. The ventricular assist devices (VAD) are used to treat end stage heart failure. The ventricular assist device is a mechanical pump that supports heart function and blood flow by taking on the workload of the left ventricle, right ventricle or both left and right ventricles helping the heart to pump oxygenated blood to the rest of the body.

Products of Ventricular assist devices market is segmented into Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD) and Biventricular Assist Devices (Bi-VAD). VAD market by pump type is segmented into Pulsating or Pneumatic Pump and Continuous Flow Pump. The continuous flow pump is further segmented into Axial flow pump and Centrifugal flow pump. VAD market by implant type is segmented into Extracorporeal VAD, Intracorporeal VAD and Percutaneous VAD. VAD market by patient type is segmented into Adult and Pediatric VAD. Applications of Ventricular assist devices are segmented into Bridge to Transplant (BTT), Bridge to destination (BTD), Bridge to Recovery (BTR).

This report concentrates on ventricular assist devices that are placed internally or externally for treating end stage heart failure. The other mechanical circulatory devices like Total artificial heart (TAH), Extracorporeal membrane oxygenation (ECMO) and Intra-aortic balloon pump (IABP) are not considered in Ventricular assist devices report.

The Ventricular assist devices global market is expected to grow at double digit CAGR to reach $2,850.1 million by 2023. Among the Ventricular assist devices products, the Left ventricular assist device market dominated the products market by occupying a largest share in 2016 and the percutaneous VAD market is the fastest growing segment during the forecasting period. In applications, Bridge to Transplantation is the largest segment and Bridge to Recovery is the fastest growing segment.

Geographical wise, North America is the largest market followed by Europe and Asia-Pacific. The APAC region is the fastest growing region with double digit CAGR from 2016 to 2023 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the ventricular assist devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.

The Ventricular assist devicesis expected to grow at a strong CAGR during 2016 to 2023. Increasing incidences of cardiovascular diseases due to change in lifestyle, shortage of donor heart, Rise in the number of heart failure, shortage of donor heart, increasing ageing population, awareness of minimally invasive procedures and newly invented devices, raise in number of clinical studies performed are some of the drivers in the ventricular assist devices global market. Many entry level barriers, stringent regulations, high cost of the device, adverse events due to VAD implant and lack of skilled and trained professionals are some of the factors hampering the growth of Ventricular assist devices market.

The ventricular assist devices global market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Ventricular assist devices are Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Abiomed (U.S.), Berlin Heart GmbH (Germany), EvaHeart (U.S.), Jarvik Heart (U.S.), Reliant Heart (U.S.), TandemLife (U.S.), etc.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
    • U.S.
    • Others
  • Europe
    • Germany
    • France
    • U.K.
    • Others
  • Asia-Pacific
    • Japan
    • China
    • India
    • Others
  • Rest of the World (RoW)
    • Brazil
    • Rest of Latin America
    • Middle East and others
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Berlin Heart Gmbh
  • Corwave
  • Fineheart Sarl
  • Leviticus-Cardio Ltd.
  • Mitiheart Corporation
  • MORE

1 Executive Summary

2 Introduction
2.1 Key Takeaways
2.2 Report Description
2.3 Markets Covered
2.4 Stakeholders
2.5 Research Methodology
2.5.1 Market Size Estimation
2.5.2 Market Breakdown and Data Triangulation
2.5.3 Secondary Sources
2.5.4 Primary Sources
2.5.5 Key Data Points from Secondary Sources
2.5.6 Key Data Points from Primary Sources
2.5.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Increase Incidence of Heart Failure
3.3.1.2 Shortage of Heart Donors
3.3.1.3 Technological Advancements in Vad
3.3.1.4 Rising Geriatric Population
3.3.1.5 Vast Pipeline Products
3.3.1.6 Expansion of Lvad Centers in Emerging Countries
3.3.1.7 New Product Launches
3.3.1.8 Increase in Funding for Lvad Research
3.3.2 Restraints and Threats
3.3.2.1 Adverse Events and Complication With the Implantations of Vad
3.3.2.2 Cost of the Devices
3.3.2.3 Stringent Regulatory Guidelines
3.3.2.4 Lack of Skilled and Trained Professionals
3.3.2.5 Availability of Alternative Products
3.3.2.6 Reimbursement Issues in Emerging Countries
3.4 Regulatory Affairs
3.4.1 International Organization for Standardization
3.4.2 U.S.
3.4.3 Canada
3.4.4 Europe
3.4.5 China
3.4.6 Japan
3.4.7 India
3.5 Reimbursement Scenario
3.5.1 Reimbursement Table
3.5.1.1 Ventricular Assist Device Reimbursement
3.5.1.2 Vad Physician Reimbursement
3.6 Clinicl Trial Data
3.7 Patent Trends
3.8 Technological Advancements
3.8.1 Introduction
3.8.2 Wireless Heart Pump
3.8.3 Miniaturization of Implantable Ventricular Assist Devices
3.8.4 Vad Application
3.8.5 Supporting Tools for Lvad Implantation
3.8.6 Percutaneous Ventricular Assist Devices
3.9 Porter’S Five Force Analysis
3.9.1 Threat of New Entrants
3.9.2 Threat of Substitutes
3.9.3 Bargaining Power of Suppliers
3.9.4 Bargaining Power of Buyers
3.9.5 Competitive Rivalry
3.10 Supply Chain Analysis
3.11 Market Share Analysis by Major Players

4 Ventricular Assist Devices Global Market, by Product
4.1 Introduction
4.2 Left Ventricular Assist Devices (Lvad)
4.3 Right Ventricular Assist Devices (Rvad)
4.4 Bi-Ventricular Assist Devices (Bivad)

5 Ventricular Assist Devices Global Market, by Implant Type
5.1 Introduction
5.2 Extracorporeal Vad
5.3 Intracorporeal Vad
5.4 Percutaneous Vad

6 Ventricular Assist Devices Global Market, by Pump Type
6.1 Introduction
6.2 Pulsatile Flow Pump
6.3 Continuous Flow Pump
6.3.1 Centrifugal Flow Pump
6.3.2 Axial Flow Pump

7 Ventricular Assist Devices Global Market, by Patient Type
7.1 Introduction
7.2 Pediatric Vad
7.3 Adult Vad

8 Ventricular Assist Devices Global Market, by Application
8.1 Introduction
8.2 Bridge to Transplant (Btt)
8.3 Bridge to Destination Therapy (Btd)
8.4 Bridge to Recovery (Btr)

9 Regional Analysis
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Others
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Others
9.4 Apac
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Others
9.5 Row
9.5.1 Brazil
9.5.2 Rest of Latin America
9.5.3 Middle East and Others

10 Company Developments
10.1 Introduction
10.2 Approvals
10.3 Acquisitions
10.4 Partnerships
10.5 Other Developments

11 Major Companies
11.1 Abbott Laboratories
11.1.1 Overview
11.1.2 Financials
11.1.3 Product Portfolio
11.1.4 Key Developments
11.1.5 Business Strategy
11.1.6 SWOT Analysis
11.2 Abiomed, Inc.
11.2.1 Overview
11.2.2 Financials
11.2.3 Product Portfolio
11.2.4 Key Developments
11.2.5 Business Strategy
11.2.6 SWOT Analysis
11.3 Berlin Heart Gmbh
11.3.1 Overview
11.3.2 Financials
11.3.3 Product Portfolio
11.3.4 Key Developments
11.3.5 Business Strategy
11.3.6 SWOT Analysis
11.4 Evaheart, Inc.
11.4.1 Overview
11.4.2 Financials
11.4.3 Product Portfolio
11.4.4 Key Developments
11.4.5 Business Strategy
11.4.6 SWOT Analysis
11.5 Fresenius Medical Care Ag & Co. Kgaa (Xenios Ag)
11.5.1 Overview
11.5.2 Financials
11.5.3 Product Portfolio
11.5.4 Key Developmnts
11.5.5 Business Strategy
11.5.6 SWOT Analysis
11.6 Jarvik Heart Inc.
11.6.1 Overview
11.6.2 Financials
11.6.3 Product Portfolio
11.6.4 Key Developmnts
11.6.5 Business Strategy
11.6.6 SWOT Analysis
11.7 Medtronic Plc
11.7.1 Overview
11.7.2 Financials
11.7.3 Product Portfolio
11.7.4 Key Developments
11.7.5 Business Strategy
11.7.6 SWOT Analysis
11.8 Reliantheart Inc.
11.8.1 Overview
11.8.2 Financials
11.8.3 Product Portfolio
11.8.4 Key Developmnts
11.8.5 Business Strategy
11.8.6 SWOT Analysis
11.9 Tandemlife
11.9.1 Overview
11.9.2 Financials
11.9.3 Product Portfolio
11.9.4 Key Developmnts
11.9.5 Business Strategy
11.9.6 SWOT Analysis

List of Tables
Table 1 Ventricular Assist Devices Global Market Revenue, by Region, (2015 - 2023) ($Mn)
Table 2 Ventricular Assist Devices Global Market Revenue, by Products, (2015-2023) ($Mn)
Table 3 Left Ventricular Assist Devices Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 4 Right Ventricular Assist Devices Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 5 Bi-Ventricular Assist Devices Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 6 Ventricular Assist Devices Global Market Revenue, by Implant Type, (2015-2023) ($Mn)
Table 7 Extracorporeal Vad Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 8 Intracorporeal Vad Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 9 Percutaneous Vad Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 10 Ventricular Assist Devices Global Market Revenue, by Pump Type, (2015-2023) ($Mn)
Table 11 Pulsatile Flow Pump Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 12 Continuous Flow Pump Global Market Revenue, by Pump Type, (2015-2023) ($Mn)
Table 13 Continuous Flow Pump Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 14 Centrifugal Flow Pump Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 15 Axial Flow Pump Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 16 Ventricular Assist Devices Global Market Revenue, by Patient Type, (2015-2023) ($Mn)
Table 17 Pediatric Vad Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 18 Adult Vad Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 19 Ventricular Assist Device Global Market Revenue, by Application, (2015-2023) ($Mn)
Table 20 Bridge to Transplant Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 21 Bridge to Destination Therapy Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 22 Bridge to Recovery Global Market Revenue, by Region, (2015-2023) ($Mn)
Table 23 Ventricular Assist Device Global Market Revenue, by Region, (2015-2023) ($Mn), Cagr (%)
Table 24 North American Ventricular Assist Devices Market Revenue, by Product, (2015-2023) ($Mn)
Table 25 North American Ventricular Assist Devices Market Revenue, by Implant Type, (2015-2023) ($Mn)
Table 26 North American Ventricular Assist Devices Market Revenue, by Pump Type, (2015-2023) ($Mn)
Table 27 North American Ventricular Assist Devices Market Revenue, by Patient Type, (2015-2023) ($Mn)
Table 28 North American Ventricular Assist Devices Market Revenue, by Application, (2015-2023) ($Mn)
Table 29 North American Ventricular Assist Devices Market Revenue, by Country, (2015-2023) ($Mn)
Table 30 Europe Ventricular Assist Devices Market Revenue, by Product, (2015-2023) ($Mn)
Table 31 Europe Ventricular Assist Devices Market Revenue, by Implant Type, (2015-2023) ($Mn)
Table 32 Europe Ventricular Assist Devices Market Revenue, by Pump Type, (2015-2023) ($Mn)
Table 33 Europe Ventricular Assist Devices Market Revenue, by Patient Type, (2015-2023) ($Mn)
Table 34 Europe Ventricular Assist Devices Market Revenue, by Application, (2015-2023) ($Mn)
Table 35 Europe Ventricular Assist Devices Market Revenue, by Country, (2015-2023) ($Mn)
Table 36 Apac Ventricular Assist Devices Market Revenue, by Product, (2015-2023) ($Mn)
Table 37 Apac Ventricular Assist Devices Market Revenue, by Implant Type, (2015-2023) ($Mn)
Table 38 Apac Ventricular Assist Devices Market Revenue, by Pump Type, (2015-2023) ($Mn)
Table 39 Apac Ventricular Assist Devices Market Revenue, by Patient Type, (2015-2023) ($Mn)
Table 40 Apac Ventricular Assist Devices Market Revenue, by Application, (2015-2023) ($Mn)
Table 41 Apac Ventricular Assist Devices Market Revenue, by Country, (2015-2023) ($Mn)
Table 42 Row Ventricular Assist Devices Market Revenue, by Product, (2015-2023) ($Mn)
Table 43 Row Ventricular Assist Devices Market Revenue, by Implant Type, (2015-2023) ($Mn)
Table 44 Row Ventricular Assist Devices Market Revenue, by Pump Type, (2015-2023) ($Mn)
Table 45 Row Ventricular Assist Devices Market Revenue, by Patient Type, (2015-2023) ($Mn)
Table 46 Row Ventricular Assist Devices Market Revenue, by Application, (2015-2023) ($Mn)
Table 47 Row Ventricular Assist Devices Market Revenue, by Country, (2015-2023) ($Mn)
Table 48 Approvals, (2015-2017)
Table 49 Acquisitions (2015-2017)
Table 50 Partnerships (2015-2017)
Table 51 Other Developments (2015-2017)
Table 52 Abbott Laboratories: Total Revenue and R&D Expenses, (2014-2016) ($Mn)
Table 53 Abbott Laboratories: Total Revenue by Segments, (2014-16) ($Mn)
Table 54 Abbott Laboratories: Total Revenue by Geography, (2014-2016) ($Mn)
Table 55 Abiomed: Total Revenue and R&D Expenses, (2014-2016) ($Mn)
Table 56 Abiomed: Total Revenue, by Segments, (2014-2016) ($Mn)
Table 57 Fresenius Medical Care: Total Revenue and R&D Expenses, (2014-2016) ($Mn)
Table 58 Fresenius Medical Care: Total Revenue, by Segments, (2014-2016) ($Mn)
Table 59 Fresenius Medical Care: Total Revenue, by Geography (2014-2016) ($Mn)
Table 60 Medtronic: Total Revenue and R&D Expenses, (2014-2016) ($Mn)
Table 61 Medtronic: Total Revenue, by Segments, (2014-2016) ($Mn)
Table 62 Medtronic: Cardiac and Vascular Group Revenue, by Segments, (2014-2016) ($Mn)
Table 63 Medtronic: Total Revenue, by Geography, (2014-2016) ($Mn)

List of Figures
Figure 1 Ventricular Assist Devices Global Market Revenue, by Region (2015-2023) ($Mn)
Figure 2 Research Methodology: Ventricular Assist Devices Global Market
Figure 3 Ventricular Assist Devices Global Market: Top-Down and Bottom-Up Approach
Figure 4 Ventricular Assist Devices Global Market: Forecasting Model
Figure 5 Ventricular Assist Devices Global Market: Market Breakdown & Data Triangulation
Figure 6 Ventricular Assist Devices Global Market Segmentation
Figure 7 Market Dynamics
Figure 8 Ventricular Assist Devices Market: Patent Filing by Major Players (2011-2016)
Figure 9 Ventricular Assist Device Global Market: Porter’S Analysis
Figure 10 Ventricular Assist Device Global Market: Supply Chain Analysis
Figure 11 Ventricular Assist Device Global Market Share Analysis, by Key Players, 2016 (%)
Figure 12 Ventricular Assist Devices Global Market Revenue, by Products (2016 V/S 2023) ($Mn)
Figure 13 Left Ventricular Assist Devices Global Market Share, by Region, (2016 V/S 2023) (%)
Figure 14 Right Ventricualr Assist Devices Global Market Share, by Region (2016 V/S 2023) (%)
Figure 15 Bi-Ventricular Assist Devices Global Market Share, by Region, (2016 V/S 2023) (%)
Figure 16 Ventricular Assist Devices Global Market Revenue, by Implant Type (2016 V/S 2023) ($Mn)
Figure 17 Extracorporeal Vad Global Market Share, by Region, (2016 V/S 2023) (%)
Figure 18 Intracorporeal Vad Global Market Share, by Region, (2016 V/S 2023) (%)
Figure 19 Percutaneous Vad Global Market Share, by Region, (2016 V/S 2023) (%)
Figure 20 Ventricular Assist Devices Global Market Revenue, by Pump Type (2016 V/S 2023) ($Mn)
Figure 21 Pulsatile Flow Pump Global Market Share, by Region, (2016 V/S 2023) (%)
Figure 22 Continuous Flow Pump Global Market Share, by Region, (2016 V/S 2023) (%)
Figure 23 Ventricular Assist Devices Global Market Revenue, by Patient Type (2016 V/S 2023) ($Mn)
Figure 24 Pediatric Vad Global Market Share, by Region, (2016 V/S 2023) (%)
Figure 25 Adult Vad Global Market Share, by Region, (2016 V/S 2023) (%)
Figure 26 Ventricular Assist Device Global Market Revenue, by Application, (2016 V/S 2023) ($Mn)
Figure 27 Bridge to Transplant Global Market Share, by Region, (2016 V/S 2023) (%)
Figure 28 Bridge to Destination Therapy Global Market Share, by Region, (2016 V/S 2023) (%)
Figure 29 Bridge to Recovery Global Market Share, by Region, (2016 V/S 2023) (%)
Figure 30 Ventricular Assist Device Global Market Revenue, by Region (2015-2023) ($Mn), Cagr (%)
Figure 31 North America Ventricular Assist Devicesrevenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 32 North America Ventricular Assist Devicesrevenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 33 U.S. Ventricular Assist Devices Market Revenue, by Products/Application (2016 V/S 2023) ($Mn)
Figure 34 U.S. Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 35 Others Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 36 Others Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 37 Europe Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 38 Europe Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 39 Germany Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 40 Germany Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 41 France Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 42 France Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 43 U.K. Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 44 U.K. Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 45 Others Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 46 Others Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 47 Apac Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 48 Apac Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 49 Japan Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 50 Japan Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 51 China Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 52 China Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 53 India Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 54 India Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 55 Others Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 56 Others Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 57 Row Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 58 Row Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 59 Brazil Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 60 Brazil Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 61 Rest of Latin America Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 62 Rest of Latin America Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 63 Middle East and Others Ventricular Assist Devices Market Revenue, by Product/Application (2016 V/S 2023) ($Mn)
Figure 64 Middle East and Others Ventricular Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type (2016 V/S 2023) ($Mn)
Figure 65 Key Growth Strategies, (2015-2017)
Figure 66 SWOT: Abbott Laboratories
Figure 67 SWOT: Abiomed
Figure 68 SWOT: Berlin Heart Gmbh
Figure 69 SWOT: Evaheart Inc.
Figure 70 SWOT: Fresenius Medical Care (Xenios Ag)
Figure 71 SWOT: Jarvik Heart, Inc.
Figure 72 SWOT: Medtronic
Figure 73 SWOT: Reliantheart, Inc.
Figure 74 SWOT: Tandemlife

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart Gmbh
  • Calon Cardio-Technology Ltd
  • Cleveland Heart, Inc.
  • Corwave
  • Evaheart, Inc.
  • Fineheart Sarl
  • Fresenius Medical Care & Co. Kgaa
  • Jarvik Heart
  • Leviticus-Cardio Ltd.
  • Medtronic Plc
  • Mitiheart Corporation
  • Procyrion
  • Reliant Heart
  • Tandemlife
  • Windmill Cardiovascular Systems, Inc.
Note: Product cover images may vary from those shown
5 of 6
The methodology is available for download below.
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll